Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Understanding DNA drug delivery for lung diseases

07.06.2005


Researchers successfully image delivery and gene expression of DNA nanoparticles into lungs of CF mice



Researchers at the American Society of Gene Therapy Meeting in St. Louis announced that by using imaging technologies, they are able to successfully trace the delivery of DNA nanoparticles and the extent of gene transfer in the lungs of cystic fibrosis (CF) animals. The study represents an important step in developing gene therapy for cystic fibrosis and other serious lung diseases.

Assem Ziady, Ph.D., assistant professor of pediatrics at the Case Western Reserve University School of Medicine, presented the results. He is conducting studies of a promising non-viral DNA nanoparticle technology that may prove to be effective in treating numerous human diseases. For this study, he collaborated with Zhenghong Lee, Ph.D., assistant professor of radiology and an expert in imaging.


In the study, Ziady and colleagues administered to CF mice DNA nanoparticles encoding a gene for an enzyme that produces light when exposed to a particular chemical. Later, the researchers could then use the emitted light to see in real time where the DNA nanoparticles had delivered the gene for expression in the lungs of the mice.

"Development of these real-time imaging modalities has allowed us to better assess the localization and site of activity of our gene transfer complex formulations," said Ziady. "Understanding gene transfer in animals is important in developing nucleic acid-based therapies to treat serious lung diseases such as cystic fibrosis."

The DNA nanoparticle technology is licensed to and being developed by Cleveland-based Copernicus Therapeutics, Inc. "Collaborations with scientists such as Dr. Ziady enable us to better develop nucleic acid therapeutics for different parts of the body and for multiple diseases," said Mark J. Cooper, M.D., senior vice president of Science and Medical Affairs of Copernicus. "Our lead program, which already has had a successful clinical trial, is development of a therapy for the lung complications of cystic fibrosis."

George Stamatis | EurekAlert!
Further information:
http://www.case.edu
http://www.cgsys.com

More articles from Life Sciences:

nachricht Multi-institutional collaboration uncovers how molecular machines assemble
02.12.2016 | Salk Institute

nachricht Fertilized egg cells trigger and monitor loss of sperm’s epigenetic memory
02.12.2016 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>